You are here

AGS-003

IPO Preview: Argos Therapeutics

Seeking Alpha

Fri, 02/7/14 - 09:30 am

Argos Therapeutics

renal cell carcinoma

Argos swings for a $60M IPO in the shadow of Dendreon's struggles

Fierce Biotech

Tue, 12/31/13 - 11:42 am

personalized medicine

renal cell carcinoma